Organization
NeuroMetrix, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
NeuroMetrix, Inc.
... WALTHAM, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its fourth quarter ...
... PAIN DEVICES Deal struck for Quell pain technology Since 2015, Waltham-based NeuroMetrix has sold more than 100,000 of its $249 Quell devices, which customers ...
... WALTHAM, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the ...
... WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported preliminary financial highlights for the fourth quarter and for ...
... WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief ...
... WALTHAM, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and ...
... NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has ...
... NeuroMetrix, Inc.(NASDAQ: NURO) today closed a $3.5 million private placement of 3,500 shares of ...
... WALTHAM, Mass. - NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended ...
... NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended ...
... WALTHAM, Mass. - NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter ...
... NeuroMetrix, Inc.(NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter ...
... WALTHAM, Mass. - NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 19th ...
... NeuroMetrix, Inc.(Nasdaq:NURO) today announced it will be a presenting company at the 19thAnnualRodman ...
... In recognition of Pain Awareness Month this September, NeuroMetrix, Inc. (Nasdaq: NURO) is partnering with the U.S. Pain Foundation , a nonprofit ...
... NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has ...
... NeuroMetrix, Inc. (Nasdaq: NURO) today reported an agreement with Fukuda Denshi for DPNCheck® distribution ...
... NeuroMetrix, Inc.(Nasdaq: NURO) reported today that it had shipped its 100,000thQuell® wearable device for ...
... NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended ...
... NeuroMetrix, Inc.(NASDAQ:NURO) announced today that it plans to issue its 2017 second quarter ...
... NeuroMetrix, Inc.(NASDAQ: NURO) announced today that it has entered into a definitive securities purchase ...
... NeuroMetrix, Inc.(Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and ...
... diabetic neuropathy market are Pfizer, Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, NeuroMetrix, Inc., Astellas Pharma Inc., Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, ...
Want to see the full history on NeuroMetrix, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial